These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24928346)

  • 1. Induction of vitiligo after imiquimod treatment of condylomata acuminata.
    Li W; Xin H; Ge L; Song H; Cao W
    BMC Infect Dis; 2014 Jun; 14():329. PubMed ID: 24928346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genital vitiligo-like depigmentation following use of imiquimod 5% cream.
    Serrão VV; Páris FR; Feio AB
    Eur J Dermatol; 2008; 18(3):342-3. PubMed ID: 18474469
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitiligo-like lesions following imiquimod 5% application for condyloma acuminata: An additional case.
    Maatouk I
    Indian J Dermatol Venereol Leprol; 2016; 82(5):572-4. PubMed ID: 27212286
    [No Abstract]   [Full Text] [Related]  

  • 4. Imiquimod-induced vitiligo in a patient with genital warts.
    Stefanaki C; Nicolaidou E; Hadjivassiliou M; Antoniou C; Katsambas A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):755-6. PubMed ID: 16836520
    [No Abstract]   [Full Text] [Related]  

  • 5. Condylomata acuminata in the neovagina after male-to-female reassignment treated with CO2 laser and imiquimod.
    Matsuki S; Kusatake K; Hein KZ; Anraku K; Morita E
    Int J STD AIDS; 2015 Jun; 26(7):509-11. PubMed ID: 24970474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?
    Serra MC; Menicanti C; Pennacchioli E; Tosti G
    An Bras Dermatol; 2014; 89(5):806-7. PubMed ID: 25184923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of locally applied imiquimod cream 5% for the treatment of condylomata acuminata of the vulva.
    Haidopoulos D; Diakomanolis E; Rodolakis A; Vlachos G; Elsheikh A; Michalas S
    Arch Gynecol Obstet; 2004 Dec; 270(4):240-3. PubMed ID: 14648072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod-induced vitiligo-like depigmentation.
    Senel E; Seckin D
    Indian J Dermatol Venereol Leprol; 2007; 73(6):423. PubMed ID: 18032867
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extensive condyloma acuminata of the penis successfully treated with 5% imiquimod cream].
    Cortés JR; Arratia J; Martínez R; Gómez L
    Actas Urol Esp; 2007 Mar; 31(3):276-8. PubMed ID: 17658157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod-induced vitiligo.
    Al-Dujaili Z; Hsu S
    Dermatol Online J; 2007 May; 13(2):10. PubMed ID: 17498429
    [No Abstract]   [Full Text] [Related]  

  • 11. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
    Cox JT
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
    Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
    AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful topical treatment of anal giant condylomata acuminata in an infant.
    Giancristoforo S; Diociaiuti A; Tchidjou HK; Lucchetti MC; Carnevale C; Rotunno R; D'Argenio P; El Hachem M
    Dermatol Ther; 2020 Jul; 33(4):e13624. PubMed ID: 32431022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of external genital warts with 5% imiquimod cream during pregnancy: a case report.
    Maw RD
    BJOG; 2004 Dec; 111(12):1475. PubMed ID: 15663141
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts.
    Brown T; Zirvi M; Cotsarelis G; Gelfand JM
    J Am Acad Dermatol; 2005 Apr; 52(4):715-6. PubMed ID: 15793538
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of recurrent and refractory cervical condylomata acuminata with topical 5% imiquimod cream in five patients.
    Ma CG; Chen MK; Yang SC; Bai S; Liao QM
    Int J STD AIDS; 2010 Jul; 21(7):528-9. PubMed ID: 20852209
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of imiquimod 5% cream for treatment of extensive anogenital warts in a seven-year-old child.
    Campaner AB; Santos RE; Galvão MA; Beznos GW; Aoki T
    Pediatr Infect Dis J; 2007 Mar; 26(3):265-6. PubMed ID: 17484228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
    Sauder DN; Skinner RB; Fox TL; Owens ML
    Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.